INM
InMed Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology · CA
$1.38
+3.76%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 7.12x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.07x
- Price / sales
- 1.83x
- Price / cash flow
- -0.82x
Enterprise value
- Enterprise value
- $2.6M
- EV / sales
- 0.64x
- EV / EBITDA
- -0.28x
- EV / EBIT
- -0.26x
- Market cap
- $7.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026